To be fair, the biggest unknown that could be huge is the up-sell into the existing customer base for VNA and the other ollogies when they're released. I assume this will be zero cost upsells if customers are enjoying the PACS. The quantum is hardest to determine as Mercy VNA deal was about 3/4 the size of PACS deal. Does this mean the latent upsell value of existing customers is 2 to 4x current PACS and just a matter or time to happen? This on top of new customer wins.
Share price holding up in down market, page-28
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$224.32 |
Change
9.700(4.52%) |
Mkt cap ! $17.90B | |||
| Open | High | Low | Value | Volume |
| $216.99 | $224.65 | $215.12 | $23.13M | 104.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 20 | $224.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $224.36 | 16 | 4 |
View Market Depth
| Last trade - 15.20pm 22/11/2024 (20 minute delay) ? |
| PME (ASX) Chart |
